NSE ScannerOpen the scanner

FMCG & Food · Food: Specialty/Candy · NSE: ADVENZYMES · data 2026-10-31

Advanced Enzyme Technologies Ltd

₹263.55-0.23% on 30 OctHealth: Average 5.9/10
Feb 2026Low ₹248.35 · High ₹392.1-8.3%

In plain words

Price: 37.1% below its 52-week high of ₹419.

Delivery: 52.8% of traded shares were kept for delivery over the last 10 sessions, against 57.7% over the last 60.

Latest results: a net profit of ₹48 cr for the quarter ended Sept 2026 (+11.5% on the same quarter a year earlier).

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹263.55
Market cap
₹2,944 cr
P/E
17.8
P/B
—
ROE
11.1%
ROCE
11.8%
Debt / equity
0.02
Dividend yield
0.51%
1-year return
-14.5%
52-week high
₹419
52-week low
₹246.8
Operating margin
24.4%

Growth

Revenue (last 12 months)₹750 cr
Net profit (last 12 months)₹166 cr
Sales growth, 3 years (yearly)11.3%
Profit growth, 3 years (yearly)16.9%

At a glance

Ownership
Moderate

Promoters 43.6% (+0.5 pts in a year), pledged 0.0%, institutions 28.5%.

Valuation
Low

P/E 17.8, dividend yield 0.5%. Price relative to earnings and book value (low is cheaper, not better).

Efficiency
Moderate

ROE 11.1%, ROCE 11.8%, operating margin 24.4%: how much profit it earns on the money it uses.

Financials
Strong

Debt/equity 0.02, Profit growth 16.9% and sales growth 11.3% a year over 3 years.

Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.

Strengths and limitations

Strengths
  • Virtually debt-free (debt/equity 0.1 or less).
  • Healthy operating margin (24.4%).
  • Profit grew 16.9% a year over 3 years.
Limitations

None flagged by these rules.

Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.

Latest results in brief (Q2 FY27)

ADVENZYMES Q2 FY27 results (consolidated figures, as filed on NSE).

Revenue was ₹214.51 crore, up 16.2% YoY and up 13% QoQ.

Net profit was ₹48.31 crore, up 11.5% YoY and up 30.3% QoQ.

Operating margin was 33.6% (32.5% a year ago).

EPS was ₹4.33, up 11.9% YoY and up 30.8% QoQ.

ADVENZYMES के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।

राजस्व: ₹214.51 करोड़; पिछले साल की तुलना में 16.2% की बढ़त, पिछली तिमाही की तुलना में 13% की बढ़त।

शुद्ध मुनाफ़ा: ₹48.31 करोड़; पिछले साल की तुलना में 11.5% की बढ़त, पिछली तिमाही की तुलना में 30.3% की बढ़त।

ऑपरेटिंग मार्जिन: 33.6% (एक साल पहले 32.5%)।

EPS: ₹4.33; पिछले साल की तुलना में 11.9% की बढ़त, पिछली तिमाही की तुलना में 30.8% की बढ़त।

ADVENZYMESના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹214.51 કરોડ; ગયા વર્ષની સરખામણીએ 16.2% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 13% વધારો.

ચોખ્ખો નફો: ₹48.31 કરોડ; ગયા વર્ષની સરખામણીએ 11.5% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 30.3% વધારો.

ઓપરેટિંગ માર્જિન: 33.6% (એક વર્ષ પહેલાં 32.5%).

EPS: ₹4.33; ગયા વર્ષની સરખામણીએ 11.9% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 30.8% વધારો.

Written from the filed numbers. Not a recommendation.

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-10-31: Q2 FY27 results: profit +11.5% YoY2026-08-08: Q1 FY27 results: profit −7.1% YoY2026-07-24: Dividend ₹1.35 (ex-date)2026-05-09: Q4 FY26 results: profit +62.2% YoY

● Results   ● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (consolidated)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Sept 2026₹215 cr₹48 cr+11.5%33.6%4.33
Jun 2026₹190 cr₹37 cr-7.1%26.9%3.31
Mar 2026₹203 cr₹43 cr+62.2%31.1%3.84
Dec 2025₹172 cr₹43 cr+12.9%28.7%3.8

Shareholding trend

HolderSept 2026Jun 2026Mar 2026Dec 2025
Promoters43.56%43.24%43.26%43.04%
Foreign institutions (FII)26.65%26.71%25.49%25.86%
Domestic institutions (DII)1.89%4.78%5.41%5.51%
Mutual funds1.18%1.82%1.93%2.16%
Retail investors17.12%15.48%16.22%16.11%
Number of shareholders67,46863,59966,19368,051

Common questions

What was Advanced Enzyme Technologies Ltd's latest quarterly profit?

Advanced Enzyme Technologies Ltd reported a net profit of ₹48 cr for the quarter ended Sept 2026 (+11.5% on the same quarter a year earlier), on revenue of ₹215 cr.

How much do promoters hold in Advanced Enzyme Technologies Ltd?

Promoters held 43.56% of Advanced Enzyme Technologies Ltd at the end of Sept 2026, with 0.00% of promoter shares pledged.

Is Advanced Enzyme Technologies Ltd debt-free?

Its latest reported debt-to-equity ratio is 0.02, which is very low.

What is Advanced Enzyme Technologies Ltd's P/E ratio?

About 17.8, based on the last 12 months' earnings and a price of ₹263.55 (data 2026-10-31).

What is the 52-week high and low of Advanced Enzyme Technologies Ltd?

The 52-week high is ₹419 and the 52-week low is ₹246.8.

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
Advanced Enzyme Technologies Ltd₹263.55₹2,944 cr17.8—11.1%11.8%0.02-14.5%
Yasho Industries Ltd.₹3,224.5₹3,890 cr67.4—5.8%8.4%1.26+105.4%
Gopal Snacks Limited₹242.1₹3,024 cr35.9—16.7%12.2%0.32-31.3%
ADF Foods Limited₹235.35₹2,557 cr28.1—16.9%11.6%0.1+5.7%
Tasty Bite Eatables Ltd₹9,733₹2,495 cr69.5—10.8%8.6%0.12+6.4%
Prataap Snacks Ltd.₹1,049.2₹2,486 cr218.2—1.4%1.8%0.06-1.2%

Compare ADVENZYMES with YASHO in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ADVENZYMES in NSE Scanner →
Share on WhatsAppShare on Telegram